(Press-News.org) In a new JAMA Viewpoint, Lainie Friedman Ross, MD, PhD, chair of the Department of Health Humanities and Bioethics at the University of Rochester Medical Center, and Mark Navin, PhD, chair of Philosophy at Oakland University, argue that America’s vaccine policy demands a new approach.
Their article, “America’s Vaccine Policy Whiplash — Finding the Way Forward,” lays out a practical middle-ground framework: acknowledge shared blame, abandon absolutist tactics that have fueled public backlash, and rebuild trust through smarter, community-based education and outreach.
“There’s plenty of blame to go around,” write the authors. “But the medical community must own its share if we’re going to rebuild trust.”
Why this matters
Ross and Navin describe recent federal and state actions that have destabilized vaccine policy, including a proposal by Florida’s Surgeon General to eliminate all of the state’s school vaccine mandates, which have been the backbone of U.S. immunization policy since the 1960s.
Vaccination rates were already declining before these changes, and outbreaks of vaccine-preventable diseases are now on the rise. National non-medical exemption (NME) rates for school vaccine mandates rose to 3.6% in 2024–25, up from 2.5% pre-pandemic. Seventeen states now report exemption rates above 5%, while 39 of 50 states have dropped below the 95% MMR coverage target for herd immunity.
The results are clear: measles cases jumped from 285 in 2024 into the thousands in 2025, including the first three U.S. measles fatalities in a decade.
How did we get here?
While politics has accelerated today’s crisis, Ross and Navin argue that the medical community must also confront its role. After the 2015 Disneyland measles outbreak, major organizations like the American Academy of Pediatrics (AAP) and the American Medical Association (AMA) advocated aggressively for eliminating NMEs.
Pediatricians have increasingly adopted policies to dismiss families who refuse vaccines, a stance the AAP endorsed and reaffirmed as recently as last year. During the COVID pandemic, professional organizations supported restricting vaccine refusers from public spaces and the workforce.
These hardline policies, the authors argue, helped provoke today’s backlash.
The misunderstood role of mandates
Ross and Navin stress that school vaccine mandates were never primarily about coercing committed refusers. Instead, they worked as a “nudge”—creating a pro-vaccine social norm and encouraging the large group of parents who were neither enthusiastic nor opposed. Removing mandates, they argue, eliminates this nudge just as coverage is faltering and outbreaks are spreading.
“Mandates nudged the ambivalent,” the authors explain. “Eliminating them risks signaling that vaccines are unsafe,” when there is overwhelming evidence that childhood vaccines are safe and effective.
The way forward
Ross and Navin call for a reset in vaccine policy, grounded in humility and partnership. That means:
Personalized education and reminders for parents who are willing but forgetful.
Evidence-based communication training for clinicians, equipping them to engage vaccine-hesitant families with patience and skill.
Partnerships with trusted local leaders, religious organizations, and parent groups to amplify accurate, credible messages.
“Mandates were intended to be one tool among many, not a substitute for robust communication and public education,” they write. “The medical community must pivot to strategies that rebuild trust.”
END
A middle-ground framework for US vaccine policy
2025-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Potential smoking gun signature of supermassive dark stars found in JWST data
2025-10-01
The first stars in the universe formed out of pristine hydrogen and helium clouds, in the first few hundred million years after the Big Bang. New James Webb Space Telescope (JWST) observations reveal that some of the first stars in the universe could have been very different from regular (nuclear fusion-powered) stars, which have been observed and catalogued by astronomers for millennia. A recent study led by Cosmin Ilie, at Colgate University, in collaboration with Shafaat Mahmud (Colgate ’26), Jillian Paulin (Colgate ’23) at UPenn, and Katherine Freese, at The University of Texas at Austin, identifies four ...
Breast cancer and autism: Visualization of the oxytocin receptor enables new theranostic approaches
2025-10-01
Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualise and activate the oxytocin receptor. This receptor–also known as the love/bonding hormone receptor–plays a key role in processes related to social behaviour, health and disease. These tracers create new possibilities for imaging and functional analysis in various biological systems–with far-reaching implications for fundamental research as well as for breast cancer diagnostics and therapy. The development of the tracers is described in the current issue of the ...
9/11 study shows how toxic exposures may lead to blood cancers
2025-10-01
October 1, 2025—(BRONX, NY)—A study led by researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has found that mutations in blood-forming cells may explain the increased risk for leukemia and other blood disorders among first responders exposed to the 9/11 World Trade Center (WTC) disaster site and its toxic dust. The study also points to a novel strategy for use against inflammation and blood disorders associated with environmental toxins. The research was published today in Cancer Discovery, a journal of the ...
NIH grant will fund autism research replication, validation, and reproducibility center
2025-10-01
Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus have received a $5.1 million, three-year grant from the National Institutes of Health’s Autism Data Science Initiative (ADSI) to launch the Autism Replication, Validation, and Reproducibility (AR²) Center. The center aims to improve the reliability of autism research and foster public trust in the field.
“The AR² Center will serve as a scientific quality control hub for the ADSI teams and projects,” said the principal investigator, Dr. Judy Zhong, chief of the Division of Biostatistics in the Department of Population ...
New AI enhances the view inside fusion energy systems
2025-10-01
Imagine watching a favorite movie when suddenly the sound stops. The data representing the audio is missing. All that’s left are images. What if artificial intelligence (AI) could analyze each frame of the video and provide the audio automatically based on the pictures, reading lips and noting each time a foot hits the ground?
That’s the general concept behind a new AI that fills in missing data about plasma, the fuel of fusion, according to Azarakhsh Jalalvand of Princeton University. Jalalvand is the lead author on a paper ...
Combined resources will improve cardiovascular-kidney-metabolic care
2025-10-01
For Release 8 a.m. CT/9 a.m. ET, Wednesday, Oct. 1, 2025
DALLAS and KANSAS CITY — The American Heart Association, devoted to changing the future to a world of healthier lives for all, has acquired program assets of the Cardiometabolic Center Alliance (CMCA) collaborative, strengthening the efforts of both organizations to establish integrated care that holistically manages cardiovascular, kidney, and metabolic health.
The missions of the CMCA and American Heart Association are closely aligned, focusing on comprehensive risk reduction and improving the quality of care and outcomes of patients with cardiometabolic disease. In addition, they both aim to accomplish these goals by supporting ...
Chatbots the new ‘doc?’ FAU researchers explore AI in health behavior coaching
2025-10-01
Changing health habits – like quitting smoking, exercising more, or sticking to prescribed treatments – is difficult but crucial for preventing and managing chronic diseases. Motivational interviewing (MI), a patient-centered counseling method that helps people find their own motivation to change, has proven effective across many health care settings.
Yet despite strong evidence, MI is not widely used in clinical practice due to challenges like limited time, training demands and payment barriers. Advances in artificial intelligence, however, are opening new possibilities to bring MI to more people through digital tools.
AI-powered chatbots, apps and ...
A step toward diagnosing the flu with your tongue
2025-10-01
Flu season is fast approaching in the northern hemisphere. And a taste-based influenza test could someday have you swapping nasal swabs for chewing gum. A new molecular sensor has been designed to release a thyme flavor when it encounters the influenza virus. Researchers reporting in ACS Central Science say that they plan to incorporate this type of low-tech sensor into gum or lozenges to increase at-home screenings and potentially prevent pre-symptomatic transmission of the disease.
Staying home is critical to preventing ...
Pathogenic yeast strains found in urban air but not along the coast
2025-10-01
As city dwellers may know, escaping to the beach can provide a much-needed change of scenery or a mental reset. Historically, some doctors even prescribed trips to the sea to treat diseases. And now, research published in ACS’ Environmental Science & Technology Letters provides another reason to visit the coast. A pilot study found that urban air contained pathogenic strains of Candida yeast that were absent in coastal air samples, revealing a potential transmission method.
Candida yeasts are a group of common microbes that exist harmlessly on people’s skin and in ...
NYU Grossman School of Medicine leader to receive the 2025 Research Achievement Award
2025-10-01
Embargoed until 7 a.m. CT/8 a.m. ET, Wednesday, Oct. 1, 2025
DALLAS, Oct. 1, 2025 — Judith S. Hochman, M.D., FAHA, senior associate dean for clinical sciences and founding director of the Cardiovascular Clinical Research Center at NYU Grossman School of Medicine in New York City, will be recognized with the 2025 Research Achievement Award at the American Heart Association’s Scientific Sessions 2025. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice ...